Validation of a commercially available SARS-CoV-2 serological immunoassay

OBJECTIVES: To validate the diagnostic accuracy of a Euroimmun SARS-CoV-2 IgG and IgA immunoassay for COVID-19. METHODS: In this unmatched (1:2) case-control validation study, we used sera of 181 laboratory-confirmed SARS-CoV-2 cases and 326 controls collected before SARS-CoV-2 emergence. Diagnostic...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Clin Microbiol Infect
Glavni autori: Meyer, B., Torriani, G., Yerly, S., Mazza, L., Calame, A., Arm-Vernez, I., Zimmer, G., Agoritsas, T., Stirnemann, J., Spechbach, H., Guessous, I., Stringhini, S., Pugin, J., Roux-Lombard, P., Fontao, L., Siegrist, C.-A., Eckerle, I., Vuilleumier, N., Kaiser, L.
Format: Artigo
Jezik:Inglês
Izdano: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2020
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7320699/
https://ncbi.nlm.nih.gov/pubmed/32603801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmi.2020.06.024
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items